Astal Laboratories [ASTALLTD] vs Future Enterprises [FELDVR] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Astal Laboratories Ltd. wins in 13 metrics, Future Enterprises Ltd. wins in 4 metrics, with 0 ties. Astal Laboratories Ltd. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Astal Laboratories Ltd. | Future Enterprises Ltd. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 8.92 | -0.05 | Astal Laboratories Ltd. |
| Price-to-Book Ratio | 1.57 | 0.06 | Future Enterprises Ltd. |
| Debt-to-Equity Ratio | 29.18 | -28.41 | Astal Laboratories Ltd. |
| PEG Ratio | -0.66 | N/A | N/A |
| EV/EBITDA | 5.91 | -46.57 | Astal Laboratories Ltd. |
| Profit Margin (TTM) | 7.11% | -131.19% | Astal Laboratories Ltd. |
| Operating Margin (TTM) | 6.03% | -97.99% | Astal Laboratories Ltd. |
| EBITDA Margin (TTM) | 6.03% | N/A | N/A |
| Return on Equity | 24.80% | -238.27% | Astal Laboratories Ltd. |
| Return on Assets (TTM) | 14.09% | -5.11% | Astal Laboratories Ltd. |
| Free Cash Flow (TTM) | $-182.92M | $3.90B | Future Enterprises Ltd. |
| 1-Year Return | -8.03% | -31.58% | Astal Laboratories Ltd. |
| Price-to-Sales Ratio (TTM) | 1.95 | 0.07 | Future Enterprises Ltd. |
| Enterprise Value | $762.07M | $76.07B | Future Enterprises Ltd. |
| EV/Revenue Ratio | 0.55 | 3.47 | Astal Laboratories Ltd. |
| Gross Profit Margin (TTM) | 9.78% | -43.00% | Astal Laboratories Ltd. |
| Revenue per Share (TTM) | $135 | $46 | Astal Laboratories Ltd. |
| Earnings per Share (Diluted) | $7.13 | $-30.54 | Astal Laboratories Ltd. |
| Beta (Stock Volatility) | -0.55 | 0.27 | Astal Laboratories Ltd. |
Astal Laboratories Ltd. vs Future Enterprises Ltd. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Astal Laboratories Ltd. | 4.96% | 13.85% | -0.82% | 12.34% | -6.74% | -7.93% |
| Future Enterprises Ltd. | 4.62% | 4.62% | 2.26% | -3.89% | -15.79% | -13.38% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Astal Laboratories Ltd. | -8.03% | 71.50% | 71.50% | 71.50% | 71.50% | 71.50% |
| Future Enterprises Ltd. | -31.58% | -38.82% | -81.69% | -85.47% | -97.92% | -99.12% |
Performance & Financial Health Analysis: Astal Laboratories Ltd. vs Future Enterprises Ltd.
| Metric | ASTALLTD | FELDVR |
|---|---|---|
| Market Information | ||
| Market Cap | ₹2.68B | ₹1.49B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 43,550 | 4,402 |
| 90 Day Avg. Volume | 25,611 | 4,188 |
| Last Close | ₹81.11 | ₹2.72 |
| 52 Week Range | ₹60.45 - ₹103.20 | ₹2.35 - ₹3.90 |
| % from 52W High | -21.41% | -30.26% |
| All-Time High | ₹131.70 (Sep 09, 2024) | ₹588.49 (Dec 31, 2007) |
| % from All-Time High | -38.41% | -99.54% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 2.65% | -0.13% |
| Quarterly Earnings Growth | -0.05% | -0.13% |
| Financial Health | ||
| Profit Margin (TTM) | 0.07% | -1.31% |
| Operating Margin (TTM) | 0.06% | -0.98% |
| Return on Equity (TTM) | 0.25% | -2.38% |
| Debt to Equity (MRQ) | 29.18 | -28.41 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹40.48 | ₹52.91 |
| Cash per Share (MRQ) | ₹4.63 | ₹0.34 |
| Operating Cash Flow (TTM) | ₹-116,989,000 | ₹4.00B |
| Levered Free Cash Flow (TTM) | ₹89.25M | ₹13.64B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | ₹0.00 |
Valuation & Enterprise Metrics Analysis: Astal Laboratories Ltd. vs Future Enterprises Ltd.
| Metric | ASTALLTD (Apr 24, 2026) | FELDVR (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 8.92 | -0.05 |
| Forward P/E | N/A | N/A |
| PEG Ratio | -0.66 | N/A |
| Price to Sales (TTM) | 1.95 | 0.07 |
| Price to Book (MRQ) | 1.57 | 0.06 |
| Market Capitalization | ||
| Market Capitalization | ₹2.68B | ₹1.49B |
| Enterprise Value | ₹762.07M | ₹76.07B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.55 | 3.47 |
| Enterprise to EBITDA | 5.91 | -46.57 |
| Risk & Other Metrics | ||
| Beta | -0.55 | 0.27 |
| Book Value per Share (MRQ) | ₹40.48 | ₹52.91 |
Financial Statements Comparison: Astal Laboratories Ltd. vs Future Enterprises Ltd.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | ASTALLTD (2025) | FELDVR (2022) |
|---|---|---|
| Revenue/Sales | 642.31M | 21.93B |
| Cost of Goods Sold | 484.81M | 20.27B |
| COGS % of Revenue | 75.5% | 92.4% |
| Gross Profit | 157.50M | 1.66B |
| Gross Margin | 24.5% | 7.6% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | 125.53M | -8.29B |
| Operating Margin | 19.5% | -37.8% |
| EBITDA | 129.01M | -3.45B |
| EBITDA Margin | 20.1% | -15.7% |
| Pre-Tax Income | 119.78M | -31.73B |
| Pre-Tax Income % of Revenue | 18.6% | -144.7% |
| Income Tax | 30.52M | 0 |
| Income Tax % of Revenue | 4.8% | 0.0% |
| Net Income (Profit) | 89.25M | -31.73B |
| Profit Margin | 13.9% | -144.7% |
Balance Sheet & Liquidity Metrics
| Metric | ASTALLTD (2025) | FELDVR (2022) |
|---|---|---|
| Cash & Equivalents | 17.30M | 64.40M |
| Total Current Assets | 456.39M | 30.32B |
| Total Current Assets % of Revenue | 71.1% | 138.2% |
| Total Current Liabilities | 267.71M | 82.76B |
| Total Current Liabilities % of Revenue | 41.7% | 377.3% |
| Long-Term Debt | 4.56M | 3.14B |
| Long-Term Debt % of Revenue | 0.7% | 14.3% |
| Total Shareholders Equity | 359.95M | -2.63B |
| Retained Earnings | 107.05M | N/A |
| Retained Earnings % of Revenue | 16.7% | 0.0% |
| Property, Plant & Equipment | 0 | 32.07B |
Cash Flow Statement Comparison
| Metric | ASTALLTD (2025) | FELDVR (2022) |
|---|---|---|
| Operating Cash Flow | -116.99M | -16.24B |
| Operating Cash Flow % of Revenue | -18.2% | -74.1% |
| Capital Expenditures | -57.75M | -100.30M |
| Free Cash Flow | -182.92M | 3.90B |
| FCF Margin | -28.5% | 17.8% |
| Debt Repayment | -547,000 | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | ASTALLTD | FELDVR |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 42.22M | 494.31M |
| Float Shares | 5.68M | 322.98M |
| % Held by Insiders | 66.12% | 72.22% |
| % Held by Institutions | 0.00% | 0.00% |
| % Held by Public | 33.88% | 27.78% |
Dividend Analysis & Yield Comparison: Astal Laboratories Ltd. vs Future Enterprises Ltd.
| Metric | ASTALLTD | FELDVR |
|---|---|---|
| Last 12-Month Dividend | N/A | ₹0.00 |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | ₹0.00 |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | ₹0.00 |
| Ex-Dividend Date | N/A | N/A |